Invention Grant
- Patent Title: Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer
-
Application No.: US16618289Application Date: 2019-04-04
-
Publication No.: US11717511B2Publication Date: 2023-08-08
- Inventor: Ki Ryang Kweon , Jun Young Heo , Min Ho Shong , Jeong Su Han , Min Jeong Ryu
- Applicant: HUEN Co., Ltd.
- Applicant Address: KR Cheonan-si
- Assignee: HUEN CO., LTD.
- Current Assignee: HUEN CO., LTD.
- Current Assignee Address: KR Cheonan-si
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Priority: KR 20180040884 2018.04.09 KR 20180040895 2018.04.09 KR 20180040913 2018.04.09
- International Application: PCT/KR2019/004001 2019.04.04
- International Announcement: WO2019/198976A 2019.10.17
- Date entered country: 2019-11-29
- Main IPC: C07D263/60
- IPC: C07D263/60 ; C07D413/04 ; C07D417/04 ; C07D401/04 ; C07D405/04 ; A61P35/00 ; A61P35/02 ; A61K31/4184 ; A61K31/4192 ; A61K31/423 ; A61K31/428 ; A61K31/4745
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating solid cancer and blood cancers such as acute leukemia and chronic leukemia, comprising a derivative compound of 1,2-naphthoquinone or a pharmaceutically acceptable salt thereof as an effective component. The derivative compound of 1,2-naphthoquinone is highly effective in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus can be beneficially used as a pharmaceutical composition for preventing or treating cancers, especially solid cancers, acute leukemia, and chronic leukemia.
Public/Granted literature
Information query
